Vise Technologies’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,022
Closed -$220K 355
2023
Q3
$220K Buy
+2,022
New +$224K 0.05% 302
2023
Q2
Sell
-1,940
Closed -$242K 348
2023
Q1
$242K Sell
1,940
-428
-18% -$58.8K 0.06% 287
2022
Q4
$356K Buy
2,368
+132
+6% +$20.3K 0.11% 201
2022
Q3
$302K Buy
+2,236
New +$342K 0.11% 207

Other funds holding BNTX

Vise Technologies's BNTX Position: Q4 2023 in Review

Vise Technologies sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 2,022 shares — an estimated $220K sold.

Vise Technologies first reported a position in BNTX in Q3 2022 and held it in 4 quarters. The position peaked at $356K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

  • Vise Technologies reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
  • Vise Technologies sold 2,022 BioNTech shares in Q4 2023, an estimated $220K.
  • Vise Technologies first reported a position in BioNTech in Q3 2022 and held it in 4 quarters.
  • Vise Technologies's BioNTech position peaked at $356K in Q4 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Vise Technologies's 13F filing for Q4 2023, filed 8 Feb 2024.